Close Menu

Rockefeller University

At Scientific American, a trio calls on community leaders, scientists, and others to prevent increased racial and economic disparities in science due to pandemic-related school closures.

The charity also announced a partnership with Sage Bionetworks to establish an online repository for biomarker data generated by grant recipients.

The team believes that the project will find genetic factors involved in the development of severe COVID-19 in patients that lack risk factors. 

Wired reports that researchers are analyzing the DNA fish leave behind in water to study their populations.

Using 350 human genomes from different populations, the two centers plan to develop a multi-genome reference sequence that is as complete as possible.

For a Breakthrough

Winners of this year's Breakthrough Prize in the life sciences include researchers who studied neurodegenerative disorders and protein folding.

Illumina is contributing reagents for 100 genomes worth of short-read sequence data to help scientists generate 100 new high-quality reference genomes.

With deep learning, researchers profiled de novo noncoding variants in individuals with ASD from nearly 1,800 families, identifying regulatory factors and related pathways.

Researchers identified immune activity changes in first-trimester placenta and decidua samples profiled through single-cell RNA sequencing.

With long-read sequencing, mapping, and other approaches, researchers assembled a high-quality genome for Aedes aegypti, a notorious infectious disease vector.

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.